Mycocycle

High-Level Overview

Mycocycle is a woman-owned biotechnology startup founded in 2018 that develops mycoremediation technology—a patent-pending process using fungi (mycelium) to detoxify and transform industrial waste, such as construction debris like asphalt shingles, carpet fibers, tires, gypsum, and rubber, into low-carbon, bio-based raw materials.[1][2][3][5] These materials, branded as MycoFILL, MycoFIBER, and MycoFOAM, serve waste management companies, landfill operators, material recycling facilities, manufacturers, and advanced materials producers by replacing virgin resources and plastic polymers, reducing CO2 emissions, and enabling circular economies in construction and manufacturing.[1][2][3] The company solves the global waste crisis—where industrial streams like construction account for one-third of waste volume—by processing toxins via biosorption, bioconversion, and biodegradation in 2-4 weeks, producing non-toxic biomass for new products while diverting waste from landfills.[1][3][6]

With headquarters in Bolingbrook, Illinois (near Chicago), Mycocycle has raised $5.8M total funding across three rounds, including a recent $3.6M, fueling operational expansion, team growth, and byproduct validation; it now operates in a facility five times larger and is filling commercial orders.[2][4][5]

Origin Story

Mycocycle was founded in 2018 by Joanne Rodriguez, its CEO, who drew inspiration from fungi's natural ability to clean and build ecosystems.[2][3][4][6] Rodriguez, selected for Argonne National Labs’ Chain Reaction Innovations Cohort 6, bootstrapped the idea to address construction waste challenges, starting in a small Chicago-area space.[2][4] Early traction came from partnerships like Closed Loop Partners’ Ventures Group, which invested in its breakthrough for circular materials from organics like carpet and tires.[2] Pivotal moments include joining The REMADE Institute (U.S. Department of Energy partnership), Startup Chicago's inaugural class, Chicago H1-B Connect for talent, and ringing the Nasdaq Closing Bell as a Chicago Innovation Award winner; these validated its tech and spurred $3.7M+ in funding for scaling.[4]

Core Differentiators

• Nature-inspired mycoremediation: Leverages engineered fungi to consume toxins from waste (e.g., oil-based rubbers, plastics) in weeks, yielding safe biomaterials superior to virgin extracts—lightweight, insulating, fire-retardant, water-repellent, and low-embodied carbon.[1][2][3][6]
• Patent-pending products: MycoFILL, MycoFIBER, MycoFOAM replace petrochemical fillers and plastics, enabling closed-loop manufacturing for construction without new resource extraction.[3]
• Rapid, low-energy process: In-situ or ex-situ treatment optimizes logistics, cuts emissions, and achieves zero-waste in 4 weeks or less, outperforming traditional recycling.[3]
• Proven scalability and validation: Expanded Chicago facility, commercial orders, life-cycle analysis projects (e.g., healthcare materials), and investor backing from Closed Loop Partners highlight real-world momentum.[2][4]

Role in the Broader Tech Landscape

Mycocycle rides the circular bioeconomy wave, targeting construction's 145 million tons of annual U.S. landfill waste (one-third global volume) amid rising regulations for carbon neutrality and material recovery.[2][3][6] Timing aligns with climate tech booms in carbon removal, waste-to-energy, and biochar, where fungi enable scalable decarbonization of "non-recyclable" streams like roofing asphalt—unlocking circularity in a $10T+ built environment.[1][2][3] Market forces like ESG mandates, landfill shortages, and demand for bio-based alternatives favor it, influencing ecosystems via REMADE Institute ties and Chicago's innovation hub, inspiring waste-to-value models across materials and manufacturing.[1][4]

Quick Take & Future Outlook

Mycocycle is poised for explosive growth, scaling Myco products into mainstream construction supply chains with recent funding enabling production ramps and validations like healthcare LCA projects.[4] Trends in bio-manufacturing, stricter emissions rules, and circular policy (e.g., DOE initiatives) will accelerate adoption, potentially expanding to new wastes while replacing high-value fillers like corn stover.[2][3] Its influence may evolve from niche innovator to ecosystem shaper, driving fungi tech standards and landfill diversion at scale—reinforcing its promise to turn the world's waste crisis into a biomaterials bonanza, as Joanne Rodriguez envisions.[6]